Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Schedule of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except share and per

share amounts):


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Basic:
Net income attributable to common stockholders	$26,322	$20,838	$96,139	$58,057
Weighted-average number of common shares	137,107,595	126,115,301	129,877,510	126,115,301
Net income per common share	$0.19	$0.17	$0.74	$0.46

Diluted:
Net income attributable to common stockholders	$26,322	$20,838	$96,139	$58,057
Weighted-average number of common shares	137,542,995	126,115,301	130,022,643	126,115,301
Net income per common share	$0.19	$0.17	$0.74	$0.46

Schedule of Earnings Per Share

The following table sets forth the components of the denominator for the computation of basic and diluted net income per

share for net income attributable to Ardent Health Partners, Inc. stockholders:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Weighted-average number of common shares - basic	137,107,595	126,115,301	129,877,510	126,115,301
Effect of dilutive securities(1)	435,400	—	145,133	—
Weighted-average number of common shares - diluted	137,542,995	126,115,301	130,022,643	126,115,301

(1) The effect of dilutive securities does not reflect 370,579 and 123,526 weighted-average potential common shares from restricted stock awards and

restricted stock units for the three and nine months ended September 30, 2024, respectively, because their effect was antidilutive as calculated under

the treasury stock method.